Using a Mounjaro Pen After 30 Days: What the Guidelines Actually Say

Each Mounjaro KwikPen contains four once-weekly doses; the 30-day room-temperature limit applies from the day you first take it out of refrigerated storage.
Once the 30-day window closes, any remaining doses in the pen should be safely discarded — potency cannot be assumed beyond this point.
Refrigerated storage between 2°C and 8°C is the baseline; the exact room-temperature window and any exceptions are set out in the Patient Information Leaflet supplied with your pen.
If storage or timing questions come up, your prescriber is the right person to contact, not the patient forum and not the bin until you're sure.

Once a Mounjaro KwikPen has been out of the fridge for 30 days, it has reached the end of its approved room-temperature storage window. Using a Mounjaro pen after 30 days at room temperature means injecting a dose whose potency and safety can no longer be guaranteed, and the manufacturer's guidance is clear: the pen should be discarded after that point, even if doses remain. Mounjaro (tirzepatide) is a prescription-only medicine — a GPhC-registered prescriber determines the right course of treatment for you. If you find yourself in this situation more often than not, the answer almost always lies in timing rather than extending the window.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What actually happens to your pen at the 30-day mark, and what to do next

You're holding a pen with doses left, here's the problem

You've been away, or the week ran away from you, and now the pen sitting on your bathroom shelf has been at room temperature for just over a month. There are still doses in it. The temptation to use the next one is understandable. A single pen is not cheap, and wasting medicine feels wrong.

The difficulty is that the 30-day limit is not an arbitrary packaging formality. Biological medicines like tirzepatide are sensitive to temperature and time outside controlled storage. The stability data that supports Mounjaro's licence covers room-temperature use up to a defined ceiling. Once that point passes, there is no clinical evidence that the medicine in the pen behaves as it should. The pen may look and feel identical (the solution is clear and colourless) but appearance is not a reliable guide to integrity for a molecule of this complexity.

The NHS patient information page for tirzepatide directs readers to the Patient Information Leaflet for storage guidance. That leaflet, published on the electronic Medicines Compendium, is the definitive source for the exact figures, and those are the figures your prescriber will use when advising you. For the precise room-temperature window and any permitted exceptions, always check the PIL that came with your pen.

The practical upshot: a pen that has been at room temperature for longer than its approved window should be disposed of responsibly. A sharps container is the correct way to dispose of the used or part-used pen, not the general household bin.

Why timing usually explains the problem, and what to adjust

Most people who find themselves with a pen past the 30-day limit hit the same snag: they started the pen, then had a disrupted few weeks. A holiday, an illness, a dose-hold advised by their prescriber. The pen sat out, the calendar ticked over.

Understanding the maths helps. Each KwikPen holds four weekly doses, meaning the pen should, under normal circumstances, last exactly four weeks from first use. If you remove it from the fridge on day one of a treatment cycle and inject every seven days, the final dose falls on day 22. There is a comfortable buffer before the 30-day limit. The window becomes tight only when a dose is delayed or held.

If delays are a recurring feature of your treatment, the right conversation is with your prescriber about how to handle them: whether to leave pens in the fridge until the day of injection, how to manage a planned holiday, or what to do if a dose is genuinely missed. Our frequently asked questions cover some common storage queries, but your prescriber should always be your first call for anything specific to your regimen. You can also read more about how to use your Mounjaro pen correctly from the start of a new cycle.

The broader question of whether a pen has expired is covered in more detail on our page about whether Mounjaro expires after 30 days.

What the evidence says about Mounjaro's effectiveness, so you understand what you're protecting

It's worth pausing on why any of this matters at the level of your results. In the SURMOUNT-1 trial, involving thousands of adults with obesity, tirzepatide at the highest dose produced an average body-weight reduction of around 20–21% over 72 weeks. Those results were achieved with correctly stored, correctly timed injections every week. There is no equivalent data for medicine used outside its stability window.

Mounjaro works by activating two gut-hormone receptors (GIP and GLP-1) in a way that reduces appetite and slows gastric emptying. It is the only dual-agonist weight-loss medicine licensed in the UK. That mechanism depends on the molecule arriving intact. A degraded dose does not simply work less well in a predictable, proportionate way; it may not work as intended at all, and the safety profile of a compromised dose is unknown.

NICE's appraisal of tirzepatide, published as TA1026, reflects the clinical evidence base built on correctly used medicine. If you're curious about how refrigerated storage affects the pen's shelf life, that is a separate consideration with its own guidance in the PIL.

Understanding the cost context helps too. The question of how Mounjaro is priced in the UK is one many people research when thinking about whether to stretch a pen, but discarding a compromised pen and starting a fresh one is the right clinical call, even when it feels costly.

What to do right now if you're unsure about your pen

If you are genuinely uncertain whether your pen is still within its approved window, stop and count back. When did you first remove it from the fridge? If you cannot be sure, treat the pen as expired. The risk of injecting a degraded dose is not measurable in the moment, but it is real.

Contact your prescriber. At nume, a real clinician reviews your case, not a system, not a chatbot. If you have a question about your current pen, our support team can connect you with the clinical team, seven days a week. Questions about what can happen if a pen is used after the 30-day window are ones our prescribers take seriously.

If you are approaching the end of a treatment cycle and want to understand your options, our overview of Mounjaro for weight management explains the treatment from the beginning. And if you'd like to check whether treatment is right for you or discuss how your current plan is going, you're welcome to speak to our prescribers, there's no obligation and no pressure.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions